Elder Pharma, Kose Corp form JV to sell cosmetics in India

Kose will hold 60% stake in the JV - Kose Elder (India) Pvt Ltd - while Elder will have the rest

Press Trust of India New Delhi
Last Updated : Mar 19 2013 | 4:55 PM IST
Drug firm Elder Pharmaceuticals today said it has formed a joint venture with Japan's Kose Corporation to manufacture and sell cosmetics in India.

Kose will hold 60% stake in the JV - Kose Elder (India) Pvt Ltd - while Elder will have the rest, Elder Pharma said in a statement.

"Kose products will be produced in the existing plant of Elder Pharmaceuticals in Paonta Sahib in Himachal Pradesh," Elder Pharma Joint Managing Director Alok Saxena said.

Also Read

The company is looking at getting the project on-stream in the next three months, he added.

Saxena said, "The initial investments could run into couple of million dollars. We have not finalised business plan as yet, but we are looking at giving them complete support of manufacturing and distribution in Indian market."

He added that the JV will manufacture all kinds of skin care products including creams, lotions and ointment.

"We plan to bring their top-end products in the Indian market using our distribution and manufacturing support they will be able to do well in Indian market. Our incremental revenues could run between Rs 30-40 crore in the first year," Saxena said.

Kose Corporation is one of the leading Japanese cosmetic companies.

Elder Pharma scrip closed at Rs 304.50 on the BSE, down 1.46% from the previous close.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 19 2013 | 4:54 PM IST

Next Story